Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy Vassago1

Karyopharm Therapeutics Inc.
Start price
€2.14
31.07.26 / 50%
Target price
-
31.07.27
Performance (%)
-21.03%
End price
€1.69
02.08.26
Summary
This prediction ended on 02.08.26 with a price of €1.69. The prediction for Karyopharm Therapeutics Inc. disappointed with a performance of -21.03%. Vassago1 has 50% into this prediction
Performance without dividends (%)
Name 1w
Karyopharm Therapeutics Inc. -
iShares Core DAX® 2,57 %
iShares Nasdaq 100 4,86 %
iShares Nikkei 225® 5,59 %
iShares S&P 500 3,25 %

According to Vassago1 what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Vassago1 for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren

Buy Karyopharm Therapeutics Inc.

Vassago1 
0
Report Share
31.07.26 Buy -21.03%
In the thread Trading Karyopharm Therapeutics Inc.
Prediction Buy
Perf. (%) -21.03%
Target price
Change
Ends at 31.07.27

Buy beendet

Vassago1 
0
Report Share
02.08.26

Stopped prediction by Vassago1 for Karyopharm Therapeutics Inc.

sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.85
15.03.26
-
15.03.27
-31.09%
24.03.26

Risky Investment
Vassago1 
15.03.26 50%